inclusion criteria: 1. presence of signed and dated informed consent of volunteer for participation in this study. 2. men and women at the age of 18-85 years. 3. bodyweight index 18.5-30.0 kg/m2. 4. the negative result of the test, performed by using pcr, for the presence of sars-cov-2 rna at the stage of screening. 5. negative result for anti-sars-cov-2 igm and igg antibodies at the stage of screening. 6. no history of the diagnosis covid-19. 7. absence of close contacts with individuals, suspicious for infection sars-cov-2, or individuals, in whom the diagnosis covid-19 was confirmed in laboratory within the last 14 days. 8. absence of signs of respiratory infection within the last 14 days. 9. negative results of human immunodeficiency virus (hiv), syphilis, hepatitis b and hepatitis c tests. 10. according to historical data and results of screening examination, a volunteer has no diseases and/or conditions, which in view of investigator, may influence the safety of volunteer participation and evaluation of study results. 11. volunteer consent for using safe contraceptive methods through all the study.

inclusion criteria: 1. presence of signed and dated informed consent of volunteer for participation in this study. 2. men and women at the age of 18-85 years. 3. bodyweight index 18.5-30.0 kg/m2. 4. the negative result of the test, performed by using pcr, for the presence of sars-cov-2 rna at the stage of screening. 5. negative result for anti-sars-cov-2 igm and igg antibodies at the stage of screening. 6. no history of the diagnosis covid-19. 7. absence of close contacts with individuals, suspicious for infection sars-cov-2, or individuals, in whom the diagnosis covid-19 was confirmed in laboratory within the last 14 days. 8. absence of signs of respiratory infection within the last 14 days. 9. negative results of human immunodeficiency virus (hiv), syphilis, hepatitis b and hepatitis c tests. 10. according to historical data and results of screening examination, a volunteer has no diseases and/or conditions, which in view of investigator, may influence the safety of volunteer participation and evaluation of study results. 11. volunteer consent for using safe contraceptive methods through all the study.

inclusion criteria: presence of signed and dated informed consent of volunteer for participation in this study. men and women at the age of 18-85 years. bodyweight index 18.5-30.0 kg/m2. the negative result of the test, performed by using pcr, for the presence of sars-cov-2 rna at the stage of screening. negative result for anti-sars-cov-2 igm and igg antibodies at the stage of screening. no history of the diagnosis covid-19. absence of close contacts with individuals, suspicious for infection sars-cov-2, or individuals, in whom the diagnosis covid-19 was confirmed in laboratory within the last 14 days. absence of signs of respiratory infection within the last 14 days. negative results of human immunodeficiency virus (hiv), syphilis, hepatitis b and hepatitis c tests. according to historical data and results of screening examination, a volunteer has no diseases and/or conditions, which in view of investigator, may influence the safety of volunteer participation and evaluation of study results. volunteer consent for using safe contraceptive methods through all the study.

inclusion criteria: presence of signed and dated informed consent of volunteer for participation in this study. men and women at the age of 18-85 years. bodyweight index 18.5-30.0 kg/m2. the negative result of the test, performed by using pcr, for the presence of sars-cov-2 rna at the stage of screening. negative result for anti-sars-cov-2 igm and igg antibodies at the stage of screening. no history of the diagnosis covid-19. absence of close contacts with individuals, suspicious for infection sars-cov-2, or individuals, in whom the diagnosis covid-19 was confirmed in laboratory within the last 14 days. absence of signs of respiratory infection within the last 14 days. negative results of human immunodeficiency virus (hiv), syphilis, hepatitis b and hepatitis c tests. according to historical data and results of screening examination, a volunteer has no diseases and/or conditions, which in view of investigator, may influence the safety of volunteer participation and evaluation of study results. volunteer consent for using safe contraceptive methods through all the study.

inclusion criteria: 1. presence of signed and dated informed consent of volunteer for participation in this study. 2. men and women at the age of 18-85 years. 3. bodyweight index 18.5-30.0 kg/m2. 4. the negative result of the test, performed by using pcr, for the presence of sars-cov-2 rna at the stage of screening. 5. negative result for anti-sars-cov-2 igm and igg antibodies at the stage of screening. 6. no history of the diagnosis covid-19. 7. absence of close contacts with individuals, suspicious for infection sars-cov-2, or individuals, in whom the diagnosis covid-19 was confirmed in laboratory within the last 14 days. 8. absence of signs of respiratory infection within the last 14 days. 9. negative results of human immunodeficiency virus (hiv), syphilis, hepatitis b and hepatitis c tests. 10. according to historical data and results of screening examination, a volunteer has no diseases and/or conditions, which in view of investigator, may influence the safety of volunteer participation and evaluation of study results. 11. volunteer consent for using safe contraceptive methods through all the study.

inclusion criteria: 1. presence of signed and dated informed consent of volunteer for participation in this study. 2. men and women at the age of 18-85 years. 3. bodyweight index 18.5-30.0 kg/m2. 4. the negative result of the test, performed by using pcr, for the presence of sars-cov-2 rna at the stage of screening. 5. negative result for anti-sars-cov-2 igm and igg antibodies at the stage of screening. 6. no history of the diagnosis covid-19. 7. absence of close contacts with individuals, suspicious for infection sars-cov-2, or individuals, in whom the diagnosis covid-19 was confirmed in laboratory within the last 14 days. 8. absence of signs of respiratory infection within the last 14 days. 9. negative results of human immunodeficiency virus (hiv), syphilis, hepatitis b and hepatitis c tests. 10. according to historical data and results of screening examination, a volunteer has no diseases and/or conditions, which in view of investigator, may influence the safety of volunteer participation and evaluation of study results. 11. volunteer consent for using safe contraceptive methods through all the study.

inclusion criteria: presence of signed and dated informed consent of volunteer for participation in this study. men and women at the age of 18-85 years. bodyweight index 18.5-30.0 kg/m2. the negative result of the test, performed by using pcr, for the presence of sars-cov-2 rna at the stage of screening. negative result for anti-sars-cov-2 igm and igg antibodies at the stage of screening. no history of the diagnosis covid-19. absence of close contacts with individuals, suspicious for infection sars-cov-2, or individuals, in whom the diagnosis covid-19 was confirmed in laboratory within the last 14 days. absence of signs of respiratory infection within the last 14 days. negative results of human immunodeficiency virus (hiv), syphilis, hepatitis b and hepatitis c tests. according to historical data and results of screening examination, a volunteer has no diseases and/or conditions, which in view of investigator, may influence the safety of volunteer participation and evaluation of study results. volunteer consent for using safe contraceptive methods through all the study.

inclusion criteria: presence of signed and dated informed consent of volunteer for participation in this study. men and women at the age of 18-85 years. bodyweight index 18.5-30.0 kg/m2. the negative result of the test, performed by using pcr, for the presence of sars-cov-2 rna at the stage of screening. negative result for anti-sars-cov-2 igm and igg antibodies at the stage of screening. no history of the diagnosis covid-19. absence of close contacts with individuals, suspicious for infection sars-cov-2, or individuals, in whom the diagnosis covid-19 was confirmed in laboratory within the last 14 days. absence of signs of respiratory infection within the last 14 days. negative results of human immunodeficiency virus (hiv), syphilis, hepatitis b and hepatitis c tests. according to historical data and results of screening examination, a volunteer has no diseases and/or conditions, which in view of investigator, may influence the safety of volunteer participation and evaluation of study results. volunteer consent for using safe contraceptive methods through all the study.

inclusion criteria: 1. presence of signed and dated informed consent of volunteer for participation in this study. 2. men and women at the age of 18-85 years. 3. bodyweight index 18.5-30.0 kg/m2. 4. the negative result of the test, performed by using pcr, for the presence of sars-cov-2 rna at the stage of screening. 5. negative result for anti-sars-cov-2 igm and igg antibodies at the stage of screening. 6. no history of the diagnosis covid-19. 7. absence of close contacts with individuals, suspicious for infection sars-cov-2, or individuals, in whom the diagnosis covid-19 was confirmed in laboratory within the last 14 days. 8. absence of signs of respiratory infection within the last 14 days. 9. negative results of human immunodeficiency virus (hiv), syphilis, hepatitis b and hepatitis c tests. 10. according to historical data and results of screening examination, a volunteer has no diseases and/or conditions, which in view of investigator, may influence the safety of volunteer participation and evaluation of study results. 11. volunteer consent for using safe contraceptive methods through all the study.

inclusion criteria: 1. presence of signed and dated informed consent of volunteer for participation in this study. 2. men and women at the age of 18-85 years. 3. bodyweight index 18.5-30.0 kg/m2. 4. the negative result of the test, performed by using pcr, for the presence of sars-cov-2 rna at the stage of screening. 5. negative result for anti-sars-cov-2 igm and igg antibodies at the stage of screening. 6. no history of the diagnosis covid-19. 7. absence of close contacts with individuals, suspicious for infection sars-cov-2, or individuals, in whom the diagnosis covid-19 was confirmed in laboratory within the last 14 days. 8. absence of signs of respiratory infection within the last 14 days. 9. negative results of human immunodeficiency virus (hiv), syphilis, hepatitis b and hepatitis c tests. 10. according to historical data and results of screening examination, a volunteer has no diseases and/or conditions, which in view of investigator, may influence the safety of volunteer participation and evaluation of study results. 11. volunteer consent for using safe contraceptive methods through all the study.